Tempus AI builds data and AI platforms for precision medicine, with a strong emphasis on oncology. It aggregates clinical and molecular data and offers sequencing, analytics and decision-support tools used by physicians, life-science companies and researchers. The business combines laboratory testing with software and datasets intended to personalize diagnosis and treatment.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q2 2025 | 314.6 | — | -42.8 | — |
| Q3 2025 | 334.2 | — | -80 | — |
| Q4 2025 | 367.2 | — | -54.2 | — |
| Q1 2026 | 348.1 | — | -125.9 | — |
| Q2 2026 | 382.5 | 21.6% | 5.6 | — |
All markets — KeepWinning global stock screener
Other companies on Nasdaq: Summit Therapeutics Inc. (SMMT), Freedom Holdings Corp. (FRHC), Bio-Techne Corporation (TECH), lululemon athletica inc. (LULU), Chime Financial, Inc. (CHYM), Repligen Corporation (RGEN)